U.S. Intraoperative Imaging Market Size To Hit USD 2.41 Bn By 2033

According to latest study, the U.S. intraoperative imaging market size was estimated at USD 1.55 billion in 2023 and is projected to hit around USD 2.41 billion by 2033, growing at a CAGR of 4.51% during the forecast period from 2024 to 2033.

Get Sample Copy of Report@ https://www.novaoneadvisor.com/report/sample/8502

The U.S. intraoperative imaging market is primarily driven by the increasing demand for minimally invasive surgeries, rising prevalence of chronic diseases, and advancements in imaging technologies. Additionally, the growing geriatric population and the increasing number of surgeries performed in hospitals and ambulatory surgical centers are also contributing to the market growth. Furthermore, the development of hybrid operating rooms and the incorporation of artificial intelligence technology in intraoperative imaging systems are expected to provide lucrative opportunities for market players in the coming years.

The U.S. market for intraoperative imaging is seeing a surge due to the rise in chronic illnesses and an aging population. The percentage of Americans aged 65 and above has risen from the previous years and is expected to reach 22 percent by 2050. This demographic shift has increased the risk of various diseases, including neurological, orthopedic, and cardiac disorders. For example, in 2022, there were over 6.2 million Alzheimer's cases and over 600,000 total knee replacements in the country. According to the American Heart Association, cardiovascular disease (CVD) remains the primary cause of death in the United States, with 928,741 fatalities recorded in 2020. Among the deaths caused by CVD, coronary heart disease (CHD) accounted for the highest percentage (41.2%), followed by stroke (17.3%), other CVD (16.8%), high blood pressure (12.9%), heart failure (9.2%), and diseases of the arteries (2.6%).

The U.S. intraoperative imaging market is experiencing growth due to the increasing adoption of minimally invasive surgeries and technological advancements. As minimally invasive procedures rely heavily on imaging for indirect visualization of the surgical field, this is a major factor contributing to the growth of the market. In addition, integrating intraoperative imaging with surgical navigation systems improves procedure guidance and drives innovation through mergers, acquisitions, and collaborations among healthcare institutions and manufacturers. An example of this is the recent acquisition of IMACTIS by GE HealthCare in January 2023. This acquisition will enhance the GE HealthCare portfolio by adding IMACTIS CT-Navigation, which is used for a wide variety of minimally invasive percutaneous procedures and will improve surgical precision and patient care.

Furthermore, The development of hybrid operating rooms and the incorporation of artificial intelligence technology in intraoperative imaging systems have been major drivers of growth in the market. Hybrid operating rooms, which combine traditional surgical equipment with advanced imaging technology, provide surgeons with real-time, high-resolution images that enable them to make more accurate and precise surgical decisions. This has led to increased demand for intraoperative imaging systems that incorporate advanced imaging technology, such as MRI and CT scanning, as well as artificial intelligence algorithms that can aid in image analysis and interpretation.

Presence of key players in the U.S. is also driving the market growth. These key players are conducting clinical trials to understand the effectiveness of intraoperative devices for various surgical procedures. For instance, Lumicell, Inc. announced the findings of their clinical trial in 2023, concerning the investigation of the Lumicell Direct Visualization System (DVS) in identifying residual breast cancer post lumpectomy. Therefore, the rising number of clinical trials on intraoperative imaging devices in the U.S. is expected to drive the overall market growth in the country.

U.S. Intraoperative Imaging Market Key Takeaways

• C-arms dominated the market and accounted for 30.93% of the revenue share in 2023.
• The increasing demand for iMRI systems is estimated to make it the fastest-growing segment over the forecast period.
• Neurosurgery application has dominated the intraoperative imaging market in 2023 by capturing 31.97% revenue share.
• The orthopedic surgery segment is projected to experience the highest growth rate during the forecast period
• Hospital segment have led the U.S. intraoperative imaging market on the basis of end-use by capturing 39.55% of the total revenue in 2023.
• Ambulatory surgical centers (ASCs) are expected to witness the highest CAGR from 2024 to 2033

Immediate Delivery Available, Get Full Access@ https://www.novaoneadvisor.com/report/checkout/8502

U.S. Intraoperative Imaging Market Recent Developments

• In February 2024, Royal Philips introduced the Philips Image Guided Therapy Mobile C-arm System 9000-Zenition 90 Motorized, designed to enhance surgical care accessibility, which offers tailored capabilities for complex vascular needs and various clinical procedures and provides surgeons with table-side control, high-quality images, and automated workflows.
• In December 2023, Royal Philips showcased its innovations at the Radiological Society of North America Scientific Sessions and Annual Meeting, focusing on enhancing workflows, efficiency, and clinical staff’s time in diagnostic imaging.
• In November 2023, Canon Medical USA, INC. and Cleveland Clinic announced a strategic partnership to develop innovative medical imaging and healthcare IT technologies. They planned to establish a comprehensive imaging research center in Cleveland’s Innovation District, focusing on cardiology, neurology, and musculoskeletal medicine. This collaboration aimed to improve diagnosis, care, and outcomes for patients.
• In July 2022, Siemens Healthineers received FDA clearance for the ARTIS icono ceiling, a ceiling-mounted angiography system offering excellent image guidance for various interventional radiology and cardiovascular procedures.
• In July 2022, Canon Medical USA, INC announced its acquisition of NXC Imaging, a distributor and service provider of capital medical equipment, strengthening the company’s sales and service channels for imaging products in the U.S. Upper Midwest.
• In September 2021, GE HealthCare acquired BK Medical, a pioneer in advanced surgical visualization. The company expects BK Medical’s expertise in intraoperative imaging and surgical navigation to help clinicians in minimally invasive and robotic surgeries and deep tissue visualization in neuro, abdominal, and urology procedures.
• In March 2021, Mindray launched the ME8 Ultrasound System in the market. Known for its lightweight and thin design, this laptop-based machine features advanced software and hardware for optimal performance.

U.S. Intraoperative Imaging Market Top Key Companies:

• GE HealthCare
• Siemens Healthcare GmbH
• Medtronic plc
• Royal Philips
• Shimadzu Corporation (Medical Systems)
• Brainlab AG
• IMRIS
• Canon Medical USA, INC.
• Shenzhen Anke High-tech Co.
• Mindray Ltd.

U.S. Intraoperative Imaging Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Intraoperative Imaging market.

By Product?

• iCT
• Intraoperative Ultrasound
• iMRI
• C-arms

By Application?

• Neurosurgery
• Cardiovascular Surgery
• Orthopedic Surgery
• Trauma /Emergency Room Surgery
• ENT Surgery
• Oncology Surgery
• Other Applications

By End-use?

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Other End-users

Immediate Delivery Available | Buy This Premium Research

https://www.novaoneadvisor.com/report/checkout/8502

U.S. Intraoperative Imaging Market - Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall U.S. Intraoperative Imaging market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Key factors that are driving the market growth include increasing demand for minimally invasive surgeries, rising prevalence of chronic diseases, and advancements in imaging technologies. Additionally, the growing geriatric population and the increasing number of surgeries performed in hospitals and ambulatory surgical centers are also contributing to the market growth.), opportunities (Growth opportunities in emerging countries), restraints (High capital investments and low cost-benefit ratio and unfavourable regulatory and reimbursement scenario), and challenges (Operational barriers) influencing the growth of the U.S. Intraoperative Imaging market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the U.S. Intraoperative Imaging market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the U.S. Intraoperative Imaging market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the U.S. Intraoperative Imaging market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like GE HealthCare; Siemens Healthcare GmbH; Medtronic plc; Royal Philips; Shimadzu Corporation (Medical Systems); Brainlab AG; IMRIS; Canon Medical USA, INC; Shenzhen Anke High-tech Co.; Mindray Ltd.

Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @

https://www.novaoneadvisor.com/report/checkout/8502

Call: USA: +1 650 460 3308 | IND: +91 87933 22019 |Europe: +44 2080772818

Email: [email protected]

Web: https://www.novaoneadvisor.com/